Portland medical device startup gets ‘breakthrough’ designation from FDA

The U.S. Food and Drug Administration has granted “Breakthrough Device” designation to a digital therapy being developed by Portland startup MedRhythms Inc.

MedRhythms’ medical device solutions use software, music and biosensors to help alleviate walking impairment in patients with neurologic disease or injury. The venture capital-backed company received the FDA designation for a solution treating stroke patients.

Breakthrough Devices are ones that meet specific FDA criteria for potentially offering more effective treatment or diagnosis of serious diseases or conditions, according to the federal agency’s website. Companies voluntarily apply for the designation, and if approved, receive close access to the FDA during product development and expedited regulatory review. Read more

Related Posts

On the Record: Roux Institute’s Lars Perkins helps startups take off

Lars Perkins, a former software entrepreneur, Google executive and certified flight instructor who once flew planes for lifesaving “adventure philanthropy,” is managing...

28 November 2022

UNE to begin building new medical school at Portland campus

The University of New England is about to start a $93 million project to move the state’s only medical school from...

28 November 2022

Portland Planning Board recommends zoning changes for Roux Institute redevelopment

The Portland Planning Board is recommending that the city adopt zoning changes requested by the developers of a new graduate school...

22 November 2022